Oracle and Ci4CC Partner to Accelerate Oncology Innovation
Go back to Oracle and Ci4CC Partner to Accelerate Oncology Innovation| Oracle Corp. (NYSE: ORCL) | Delayed: 130.20 -0.33 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.53 | 52 Week High | $42.00 | |||
| Open | $131.32 | 52 Week Low | $33.13 | |||
| Day High | $131.81 | P/E | 55.64 | |||
| Day Low | $129.41 | EPS | $2.34 | |||
| Volume | 10,884,221 | |||||



